Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Account Payables (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Change in Account Payables for 16 consecutive years, with $23000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Account Payables rose 103.11% year-over-year to $23000.0, compared with a TTM value of -$1.1 million through Sep 2025, up 18.15%, and an annual FY2024 reading of -$1.6 million, down 455.72% over the prior year.
  • Change in Account Payables was $23000.0 for Q3 2025 at Rockwell Medical, up from -$423000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.6 million in Q2 2021 and bottomed at -$2.0 million in Q3 2023.
  • Average Change in Account Payables over 5 years is -$138421.1, with a median of $23000.0 recorded in 2025.
  • The sharpest move saw Change in Account Payables soared 877.51% in 2021, then crashed 1933.03% in 2023.
  • Year by year, Change in Account Payables stood at -$1.1 million in 2021, then skyrocketed by 191.51% to $1.0 million in 2022, then tumbled by 41.42% to $587000.0 in 2023, then plummeted by 55.37% to $262000.0 in 2024, then plummeted by 91.22% to $23000.0 in 2025.
  • Business Quant data shows Change in Account Payables for RMTI at $23000.0 in Q3 2025, -$423000.0 in Q2 2025, and -$944000.0 in Q1 2025.